Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma

IMPORTANCE: The association between treatment with first-line immuno-oncology (IO) combination therapies and physician-assessed objective imaging response among patients with metastatic renal cell carcinoma (mRCC) remains uncharacterized. OBJECTIVE: To compare the likelihood of objective imaging res...

Descripción completa

Detalles Bibliográficos
Autores principales: Navani, Vishal, Ernst, Matthew, Wells, J. Connor, Yuasa, Takeshi, Takemura, Kosuke, Donskov, Frede, Basappa, Naveen S., Schmidt, Andrew, Pal, Sumanta K., Meza, Luis, Wood, Lori A., Ernst, D. Scott, Szabados, Bernadett, Powles, Thomas, McKay, Rana R., Weickhardt, Andrew, Suarez, Cristina, Kapoor, Anil, Lee, Jae Lyun, Choueiri, Toni K., Heng, Daniel Y. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187954/
https://www.ncbi.nlm.nih.gov/pubmed/35687336
http://dx.doi.org/10.1001/jamanetworkopen.2022.16379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187954/
https://www.ncbi.nlm.nih.gov/pubmed/35687336
http://dx.doi.org/10.1001/jamanetworkopen.2022.16379

Ejemplares similares